Go Pro

Octopus Titan VCT (OTV2) Competitors

Octopus Titan VCT logo
GBX 17 0.00 (0.00%)
As of 08/5/2026 12:34 PM Eastern

OTV2 vs. BPCR, EDIN, GSS, GROW, and AGT

Should you buy Octopus Titan VCT stock or one of its competitors? MarketBeat compares Octopus Titan VCT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Octopus Titan VCT include BioPharma Credit (BPCR), Edinburgh Investment (EDIN), Genesis Emerging Markets Fund (GSS), Molten Ventures (GROW), and AVI Global Trust (AGT). These companies are all part of the "asset management & custody banks" industry.

How does Octopus Titan VCT compare to BioPharma Credit?

BioPharma Credit (LON:BPCR) and Octopus Titan VCT (LON:OTV2) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

31.3% of BioPharma Credit shares are held by institutional investors. Comparatively, 0.1% of Octopus Titan VCT shares are held by institutional investors. 0.1% of BioPharma Credit shares are held by insiders. Comparatively, 0.0% of Octopus Titan VCT shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Octopus Titan VCT has a net margin of 238.29% compared to BioPharma Credit's net margin of 92.62%. BioPharma Credit's return on equity of 11.29% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
BioPharma Credit92.62% 11.29% 4.98%
Octopus Titan VCT 238.29%-15.45%-14.38%

BioPharma Credit has a beta of 0.22095597, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Octopus Titan VCT has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 721.6%. Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 2.9%. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, BioPharma Credit's average media sentiment score of 0.00 equaled Octopus Titan VCT'saverage media sentiment score.

Company Overall Sentiment
BioPharma Credit Neutral
Octopus Titan VCT Neutral

BioPharma Credit has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioPharma Credit£132.06M0.08£10.42B£11.400.09
Octopus Titan VCT-£86.81M-3.23-£173.99M-£5.50N/A

Summary

BioPharma Credit beats Octopus Titan VCT on 11 of the 13 factors compared between the two stocks.

How does Octopus Titan VCT compare to Edinburgh Investment?

Edinburgh Investment (LON:EDIN) and Octopus Titan VCT (LON:OTV2) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Edinburgh Investment pays an annual dividend of GBX 30.20 per share and has a dividend yield of 3.5%. Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 2.9%. Edinburgh Investment pays out 54.0% of its earnings in the form of a dividend. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Edinburgh Investment has a beta of 0.957, meaning that its stock price is 4% less volatile than the broader market. Comparatively, Octopus Titan VCT has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market.

Octopus Titan VCT has a net margin of 238.29% compared to Edinburgh Investment's net margin of 89.72%. Edinburgh Investment's return on equity of 7.03% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Edinburgh Investment89.72% 7.03% 6.69%
Octopus Titan VCT 238.29%-15.45%-14.38%

In the previous week, Edinburgh Investment had 1 more articles in the media than Octopus Titan VCT. MarketBeat recorded 1 mentions for Edinburgh Investment and 0 mentions for Octopus Titan VCT. Edinburgh Investment's average media sentiment score of 1.87 beat Octopus Titan VCT's score of 0.00 indicating that Edinburgh Investment is being referred to more favorably in the media.

Company Overall Sentiment
Edinburgh Investment Very Positive
Octopus Titan VCT Neutral

Edinburgh Investment has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Edinburgh Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edinburgh Investment£79.43M13.65£180.50M£55.9115.29
Octopus Titan VCT-£86.81M-3.23-£173.99M-£5.50N/A

9.7% of Edinburgh Investment shares are held by institutional investors. Comparatively, 0.1% of Octopus Titan VCT shares are held by institutional investors. 0.4% of Edinburgh Investment shares are held by company insiders. Comparatively, 0.0% of Octopus Titan VCT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Edinburgh Investment beats Octopus Titan VCT on 13 of the 15 factors compared between the two stocks.

How does Octopus Titan VCT compare to Genesis Emerging Markets Fund?

Octopus Titan VCT (LON:OTV2) and Genesis Emerging Markets Fund (LON:GSS) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

0.1% of Octopus Titan VCT shares are held by institutional investors. 0.0% of Octopus Titan VCT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Genesis Emerging Markets Fund has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Genesis Emerging Markets Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-3.23-£173.99M-£5.50N/A
Genesis Emerging Markets Fund£250.40M0.00N/A£140.70N/A

In the previous week, Octopus Titan VCT's average media sentiment score of 0.00 equaled Genesis Emerging Markets Fund'saverage media sentiment score.

Company Overall Sentiment
Octopus Titan VCT Neutral
Genesis Emerging Markets Fund Neutral

Octopus Titan VCT has a net margin of 238.29% compared to Genesis Emerging Markets Fund's net margin of 0.00%. Genesis Emerging Markets Fund's return on equity of 0.00% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT238.29% -15.45% -14.38%
Genesis Emerging Markets Fund N/A N/A N/A

Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 2.9%. Genesis Emerging Markets Fund pays an annual dividend of GBX 0.17 per share. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Genesis Emerging Markets Fund pays out 0.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Octopus Titan VCT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Octopus Titan VCT and Genesis Emerging Markets Fund tied by winning 5 of the 10 factors compared between the two stocks.

How does Octopus Titan VCT compare to Molten Ventures?

Molten Ventures (LON:GROW) and Octopus Titan VCT (LON:OTV2) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

41.0% of Molten Ventures shares are owned by institutional investors. Comparatively, 0.1% of Octopus Titan VCT shares are owned by institutional investors. 1.6% of Molten Ventures shares are owned by insiders. Comparatively, 0.0% of Octopus Titan VCT shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Molten Ventures currently has a consensus price target of GBX 638.67, suggesting a potential upside of 1.30%. Given Molten Ventures' stronger consensus rating and higher probable upside, research analysts plainly believe Molten Ventures is more favorable than Octopus Titan VCT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molten Ventures
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Octopus Titan VCT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Molten Ventures had 2 more articles in the media than Octopus Titan VCT. MarketBeat recorded 2 mentions for Molten Ventures and 0 mentions for Octopus Titan VCT. Molten Ventures' average media sentiment score of 0.00 beat Octopus Titan VCT's score of 0.00 indicating that Molten Ventures is being referred to more favorably in the media.

Company Overall Sentiment
Molten Ventures Neutral
Octopus Titan VCT Neutral

Molten Ventures has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Molten Ventures, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molten Ventures£148M7.33-£33.58M£69.009.14
Octopus Titan VCT-£86.81M-3.23-£173.99M-£5.50N/A

Molten Ventures has a beta of 1.9564402, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Octopus Titan VCT has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market.

Octopus Titan VCT has a net margin of 238.29% compared to Molten Ventures' net margin of 75.09%. Molten Ventures' return on equity of 9.21% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Molten Ventures75.09% 9.21% -3.46%
Octopus Titan VCT 238.29%-15.45%-14.38%

Summary

Molten Ventures beats Octopus Titan VCT on 15 of the 16 factors compared between the two stocks.

How does Octopus Titan VCT compare to AVI Global Trust?

Octopus Titan VCT (LON:OTV2) and AVI Global Trust (LON:AGT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

0.1% of Octopus Titan VCT shares are owned by institutional investors. Comparatively, 8.3% of AVI Global Trust shares are owned by institutional investors. 0.0% of Octopus Titan VCT shares are owned by company insiders. Comparatively, 0.1% of AVI Global Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

AVI Global Trust has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than AVI Global Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-3.23-£173.99M-£5.50N/A
AVI Global Trust£57.10M18.34£215.81M£11.7422.44

In the previous week, AVI Global Trust's average media sentiment score of 0.83 beat Octopus Titan VCT's score of 0.00 indicating that AVI Global Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Octopus Titan VCT Neutral
AVI Global Trust Positive

Octopus Titan VCT has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, AVI Global Trust has a beta of 0.95096856, indicating that its share price is 5% less volatile than the broader market.

Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 2.9%. AVI Global Trust pays an annual dividend of GBX 4.50 per share and has a dividend yield of 1.7%. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. AVI Global Trust pays out 38.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Octopus Titan VCT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Octopus Titan VCT has a net margin of 238.29% compared to AVI Global Trust's net margin of 92.40%. AVI Global Trust's return on equity of 4.87% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT238.29% -15.45% -14.38%
AVI Global Trust 92.40%4.87%7.00%

Summary

AVI Global Trust beats Octopus Titan VCT on 11 of the 14 factors compared between the two stocks.

Get Octopus Titan VCT News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTV2 and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTV2 vs. The Competition

MetricOctopus Titan VCTCapital Markets IndustryFinance SectorLON Exchange
Market Cap£280.20M£5.55B£14.03B£2.87B
Dividend Yield8.29%7.46%5.91%6.13%
P/E Ratio-3.0938.2429.34369.49
Price / Sales-3.231,242.89511.8683,955.53
Price / Cash5.4148.2339.3227.89
Price / Book0.313.743.747.07
Net Income-£173.99M£417.17M£1.31B£5.89B
7 Day Performance70.00%1.27%1.11%1.18%
1 Month PerformanceN/A-0.46%0.46%0.90%
1 Year Performance-48.48%6.59%13.14%75.31%

Octopus Titan VCT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTV2
Octopus Titan VCT
N/AGBX 17
flat
N/A-48.5%£280.20M-£86.81MN/A30
BPCR
BioPharma Credit
N/AGBX 0.97
-0.2%
N/A+11.2%£1.09B£132.06M0.08N/A
EDIN
Edinburgh Investment
N/AGBX 841.52
-0.5%
N/A+8.4%£1.08B£79.43M15.05N/A
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626
GROW
Molten Ventures
1.3939 of 5 stars
GBX 607
-1.4%
GBX 638.67
+5.2%
+78.4%£1.03B£148M8.8020

Related Companies and Tools


This page (LON:OTV2) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners